« Previous Next » International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 4 , Pages 898-903 , 15 July 2002

Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapy

These findings were presented at the 43rd Annual Meeting of the American Society for Therapeutic Radiology and Oncology in San Francisco, CA., November 2001.

Marshal E Lieberfarb, M.D., Ph.D.
- Reprint requests to: Dr. Marshal E. Lieberfarb, Joint Center for Radiation Therapy, Harvard Medical School, 330 Brookline Avenue, 5th floor, Boston, MA 02215 USA. Tel: (617) 632-7325
- Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA, USA
Delray Schultz, Ph.D.
- Department of Mathematics, University of Millersville, Millersville, PA, USA
Richard Whittington, M.D.
- Department of Pathology and Urology, University of Pennsylvania, Philadelphia, PA USA
Bruce Malkowicz, M.D.
- Department of Pathology and Urology, University of Pennsylvania, Philadelphia, PA USA
John E Tomaszewski, M.D., Ph.D.
- Department of Pathology and Urology, University of Pennsylvania, Philadelphia, PA USA
Michael Weinstein, M.D., Ph.D.
- Departments of Radiation Oncology, Urology, and Pathology, Brigham and Women’s Hospital and Dana Farber Cancer Institute, Boston, MA, USA
Alan Wein, M.D.
- Department of Pathology and Urology, University of Pennsylvania, Philadelphia, PA USA
Jerome P Richie, M.D.
- Departments of Radiation Oncology, Urology, and Pathology, Brigham and Women’s Hospital and Dana Farber Cancer Institute, Boston, MA, USA
Anthony V D’Amico, M.D., Ph.D.
- Departments of Radiation Oncology, Urology, and Pathology, Brigham and Women’s Hospital and Dana Farber Cancer Institute, Boston, MA, USA